Cencora, Inc. Common Stock (COR) stock analysis

COR · Cencora, Inc. Common Stock

Latest recorded price: USD 357.00

Model-estimated fair value: USD 269.37. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Medical Distribution

At $357.00, COR trades 32.5% above the model's base-case value of $269.37. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $202.62 in the conservative case and $347.20 in the optimistic case, with a valuation confidence score of 81/100. About 76% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 10.4%, free cash flow margin 1.0%, ROIC 19.2%. The model does not flag any risk signals for this company.

Similar companies in Healthcare